Show results for
Refine by
Pathology Clinical Articles & Analysis
13 news found
During her time at the Charité Universitätsmedizin Berlin in Germany, Blum, MD, PhD played a central role in developing a GMP-compliant clinical platform for the use of TCR based cellular therapy in refractory AML, high-risk multiple myeloma and metastatic melanoma. In the context of complex government-sponsored initiatives she was able to coordinate activities of ...
ByArdigen
In this new role, Dr. Chadha will lead all clinical and medical affairs as the company continues to develop, validate, and commercialize its AI-driven digital biomarker platform. ...
Publication of a large new study2 in the Journal of Clinical Pathology comparing the difference in turnaround time between in-house automated rapid PCR3 -based EGFR analysis and Next-Generation Sequencing (NGS) by an external laboratory, showing that 6% of the patients died before the NGS report was available. ...
Embedding this AI technology within PathPresenter’s emerging ClinPx platform – a scanner-agnostic digital pathology workflow solution – could accelerate the adoption of AI tools within clinical workflows. ...
MyOptiLab carries out complete analyses designed specifically for clinical pathology labs. It uses the Lean and Six Sigma methodologies applied widely in the industry and provides solutions for increasing productivity and improving patient quality of service. ...
“This publication shows for the first time that WATS3D helps to detect clinically-significant pathologic lesions and provides insight into the progression rates of BE and dysplasia to cancer,” said Bill Huffnagle, CEO of CDx Diagnostics. ...
Based on user analysis and evaluation of feedback from clinics, therapists and patients, we have further developed our system to relieve therapists. ...
Since lipidomics profiles are of great importance for studying developmental or pathological processes in tissue sections, MALDI-Imaging can serve as a useful tool for biomarker discovery. ...
We were pleased to see not only slowing of cognitive and functional decline, but also very substantial clearance of amyloid plaques and slowing of spread of tau pathology. The constellation of clinical and biomarker results indicates the potential for long-term disease modification. ...
In a paper published online this week in Autism Research, scientists at NeuroPointDX, a division of Stemina Biomarker Discovery, Inc., in collaboration with researchers at the UC Davis MIND Institute and academic and clinical institutions across the country, report new findings from the Children’s Autism Metabolome Project or CAMP. ...
Orringer, MD, associate professor in the Departments of Neurosurgery and Pathology. Their combined clinical and mathematical expertise will enable them to tackle questions that neither researcher could effectively address alone. ...
Data obtained in real-life setting from more than 800 patients with node-negative or nodepositive early-stage breast cancer highlight the test’s impact on clinical practice with chemotherapy-sparing effect Publication of landmark TAILORx study results led to greater reduction in chemotherapy recommendations Exact Sciences Corp. today announced results from a ...
McGuire Memorial Lecture Award at 2019 San Antonio Breast Cancer Symposium New Publication of Long-term Data from Real-world Clinical Practice Confirms Conclusions of TAILORx Exact Sciences Corp. ...